TWI733869B - Process for preparing boscalid - Google Patents

Process for preparing boscalid Download PDF

Info

Publication number
TWI733869B
TWI733869B TW106126004A TW106126004A TWI733869B TW I733869 B TWI733869 B TW I733869B TW 106126004 A TW106126004 A TW 106126004A TW 106126004 A TW106126004 A TW 106126004A TW I733869 B TWI733869 B TW I733869B
Authority
TW
Taiwan
Prior art keywords
patent application
scope
item
elevated temperature
method described
Prior art date
Application number
TW106126004A
Other languages
Chinese (zh)
Other versions
TW201808904A (en
Inventor
詹姆士 布里斯托
Original Assignee
香港商龍燈農業化工國際有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 香港商龍燈農業化工國際有限公司 filed Critical 香港商龍燈農業化工國際有限公司
Publication of TW201808904A publication Critical patent/TW201808904A/en
Application granted granted Critical
Publication of TWI733869B publication Critical patent/TWI733869B/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A process for preparing the crystalline modification II of the anhydrate of boscalid is provided, the process comprising providing a solution of boscalid in an organic solvent system, heating the solution to an elevated temperature, and precipitating solid boscalid from the solution, the elevated temperature being sufficient to preferentially form the crystalline modification II of the anhydrate of boscalid.

Description

製備白克列之方法 Method of preparing Bekley

本發明關於製備白克列之方法,特別是關於製備白克列的特定結晶形式之方法。 The present invention relates to a method for preparing buckle, and particularly to a method for preparing a specific crystalline form of buckle.

具有通用名稱為白克列的化合物2-氯-N-(4'氯[1,1'聯苯基]-2-基)-3-吡啶甲醯胺具有結構式I:

Figure 106126004-A0202-12-0001-1
The compound 2-chloro-N-(4'chloro[1,1'biphenyl]-2-yl)-3-pyridinecarboxamide with the common name Bekley has the structural formula I:
Figure 106126004-A0202-12-0001-1

白克列是羧醯胺基團之殺真菌劑,並作為琥珀酸脫氫酶抑制劑(SDHI),即線粒體的呼吸抑制劑。這種類別的羧醯亞胺化合物和該等化合物之活性首次描述於US 4,001,416和US 5,330,995中。 Bakelite is a fungicide for the carboxamide group and acts as a succinate dehydrogenase inhibitor (SDHI), that is, a respiratory inhibitor of mitochondria. Carboximine compounds of this type and the activities of these compounds were first described in US 4,001,416 and US 5,330,995.

白克列作為殺真菌劑是有活性的,並且其現在以一系列用於處理真菌感染及其所產生疾病的配製物為可商購的。 Becquel is active as a fungicide, and it is now commercially available in a series of formulations for treating fungal infections and the diseases they produce.

US 7,087,239涉及菸鹼酸苯胺和/或苯甲醯苯胺衍生物的結晶水合物。US 7,087,239中具體例示白克列的水合物的合成和回收。藉由首先製備白克列的無水物來獲得該水合物,該白克列的無水物在合成過程結束時作為熱二甲苯中的溶液獲得。冷卻後,從該溶液中結晶出白克列並且 在烘箱中於真空下乾燥。該無水物被指出具有以下物理特性: US 7,087,239 relates to crystalline hydrates of nicotinic acid aniline and/or benzaniline derivatives. US 7,087,239 specifically exemplifies the synthesis and recovery of the hydrate of Becquerie. The hydrate is obtained by first preparing an anhydrate of Becquerère, which is obtained as a solution in hot xylene at the end of the synthesis process. After cooling, the white Klei crystallized from the solution and dried in an oven under vacuum. The anhydrous is indicated to have the following physical properties:

分子量[g/mol]:343.2 Molecular weight [g/mol]: 343.2

熔點[℃](DSC):145.2 Melting point [℃] (DSC): 145.2

密度[g/mol]:1.42 Density [g/mol]: 1.42

X射線反射(2θ度):18;22.5;9.5;6 X-ray reflection (2θ degrees): 18; 22.5; 9.5; 6

Cu-Kα Cu-Kα

IR吸收[cm-1]:1650 IR absorption [cm -1 ]: 1650

含水量[%]:<1 Water content [%]: <1

US 7,087,239揭露可以藉由在40℃下在溶劑中將該無水物溶解到四氫呋喃(THF)中並將所得溶液添加到水中而形成該水合物。藉由過濾從所得混合物中分離出沈澱並乾燥,以產出白克列的單水合物。US 7,087,239中揭露的白克列無水物的結晶變體在本文中被稱作白克列的結晶變體I。 US 7,087,239 discloses that the hydrate can be formed by dissolving the anhydrate in tetrahydrofuran (THF) in a solvent at 40°C and adding the resulting solution to water. The precipitate was separated from the resultant mixture by filtration and dried to produce the monohydrate of Beakley. The crystalline modification of Bekley anhydride disclosed in US 7,087,239 is referred to herein as crystalline modification I of Bekley.

US 7,241,896涉及用於生產2-鹵素-吡啶-甲醯胺之方法,其揭露和例示白克列的製備。在該等實例中,藉由2-氯-3-菸鹼基鹵化物II與2-(4-氯苯基)苯胺在溶劑系統(具體地是二甲苯)中進行反應來合成白克列。用碳酸鈉溶液萃取後,藉由穩步冷卻有機溶液來結晶白克列。 US 7,241,896 relates to a method for the production of 2-halogen-pyridine-formamide, which discloses and exemplifies the preparation of Becquerie. In these examples, Becquerie was synthesized by reacting 2-chloro-3-nicotinyl halide II and 2-(4-chlorophenyl)aniline in a solvent system (specifically xylene). After extraction with a sodium carbonate solution, the organic solution was steadily cooled to crystallize the white Klebsiella.

我們已經發現難以在水中研磨那從US 7,087,239中揭露的白克列無水物的結晶變體。因此,直接將白克列的結晶變體配製成需要研磨和/或磨細過程的所需配製物不是一項簡單的任務。這樣的配製物是,例如粒劑,膠囊粒劑,片劑,水分散性粒劑,水分散性片劑,可溼性粉劑或用於種子處理的可溼性粉劑,粉劑配製物,以及其中活性化合物以分散形 式存在的配製物,例如水懸劑,水分散性油懸劑,濃懸乳劑或種子處理用水懸劑。在配製成水懸劑之前,需要水合白克列的結晶變體。 We have found that it is difficult to grind the crystalline modification of the buckle anhydride disclosed in US 7,087,239 in water. Therefore, it is not a simple task to directly formulate the crystalline modification of Becquerie into the desired formulation that requires a grinding and/or grinding process. Such formulations are, for example, granules, capsule granules, tablets, water-dispersible granules, water-dispersible tablets, wettable powders or wettable powders for seed treatment, powder formulations, and wherein Formulations in which the active compound is present in dispersed form, for example, aqueous suspensions, water-dispersible oil suspensions, suspension emulsions or aqueous seed treatment suspensions. Before being formulated into an aqueous suspension, the crystalline modification of Becquerie needs to be hydrated.

US 7,501,384揭露白克列無水物的所謂新穎結晶變體。US 7,501,384中揭露的結晶變體在本文中被稱作白克列的結晶變體II。在US 7,501,384中提出,白克列的結晶變體II更適合用於製造各種配製物,否則該等配製物需要長時間的研磨/磨細過程。 US 7,501,384 discloses the so-called novel crystalline modification of Becquel anhydride. The crystalline modification disclosed in US 7,501,384 is referred to herein as Bakelite's crystalline modification II. It is proposed in US 7,501,384 that Becquerie's crystalline modification II is more suitable for the manufacture of various formulations, which would otherwise require a long grinding/grinding process.

US 7,501,384描述了白克列的結晶變體II可以藉由如下方法製備,該方法包括:a)將白克列的結晶變體I的無水物溶解在極性有機溶劑或芳香族烴中;並且b)藉由冷卻該溶劑來沈澱白克列的結晶變體II的無水物。 US 7,501,384 describes that the crystalline modification II of Becquerie can be prepared by the following method, which comprises: a) dissolving the anhydrate of the crystalline modification I of Becquerie in a polar organic solvent or an aromatic hydrocarbon; and b ) Precipitating the anhydrate of the crystalline modification II of Becquerie by cooling the solvent.

US 7,501,384中揭露的製備白克列的結晶變體II之替代方法包括:a)將白克列的結晶變體I加熱至150℃以上直至熔化;並且b)藉由添加白克列的結晶變體II的晶種來冷卻該融化物。 The alternative method of preparing the crystalline modification II of Becquerie disclosed in US 7,501,384 includes: a) heating the crystalline modification I of Becquerie to above 150°C until melting; and b) by adding the crystalline modification of Becquerie Seed crystals of body II to cool the melt.

US 7,501,384描述了白克列的結晶變體II,其具有以下性質: US 7,501,384 describes the crystalline modification II of Becquerie, which has the following properties:

分子量[g/mol]:342 Molecular weight [g/mol]: 342

熔點[℃](DSC):147.2 Melting point [℃] (DSC): 147.2

熔化熱[J/g](DSC):106 Heat of fusion [J/g] (DSC): 106

密度[g/cm3]:1.457 Density [g/cm 3 ]: 1.457

特徵IR帶[cm-1]:868,917,1675 Characteristic IR band [cm -1 ]: 868, 917, 1675

使用西門子的單晶繞射儀從白克列的結晶變體II的晶體學研究中獲得的關鍵參數和晶胞矩陣是在US 7,501,384中給出: The key parameters and unit cell matrix obtained from the crystallographic study of Becquerie’s Crystal Modification II using Siemens’ single crystal diffractometer are given in US 7,501,384:

以上所示的該等參數具有以下含義:a,b,c=單位晶胞的棱長;α,β,γ=相應的角度;以及Z=單位晶胞中的分子數。 The parameters shown above have the following meanings: a, b, c = the edge length of the unit cell; α, β, γ = the corresponding angle; and Z = the number of molecules in the unit cell.

FTIR光譜法可用於記錄IR光譜。 FTIR spectroscopy can be used to record IR spectra.

如果可以提供改進的白克列無水物的結晶變體II之製備方法,特別是適用於在商業規模上應用、具有可重現的高產率的變體II產物之方法,這將是顯著的優勢。較佳的是,該方法操作簡單並且易於控制。 It would be a significant advantage if an improved preparation method for the crystalline modification II of Beclet anhydride can be provided, especially a method suitable for commercial-scale applications with reproducible and high yield of the modification II product. . Preferably, the method is simple to operate and easy to control.

出人意料的是,現在已經發現形成高產率的白克列無水物的結晶變體II是在升高的溫度下發生的。相比之下,較低的溫度導致較佳的是形成白克列無水物的晶體變體I。具體地,當從溶劑系統中沈澱白克列時,出乎意料的是發現在低溫下溶劑系統中白克列的沈澱主要或僅產生了白克列無水物的結晶變體I,然而提高溶劑系統的溫度並且沈澱固體白克列優先產生白克列無水物的結晶II變體。 Unexpectedly, it has now been discovered that the formation of crystalline modification II of the bucklean anhydride in high yield occurs at elevated temperatures. In contrast, the lower temperature leads to better formation of the crystal modification I of Becquel anhydride. Specifically, when precipitating Beakley from a solvent system, it was unexpectedly found that the precipitation of Beakley in the solvent system at low temperatures mainly or only produced the crystalline modification I of Beakley anhydrous, while increasing the solvent The temperature of the system and the precipitation of solid bacillus preferentially produce the crystalline II variant of baccladium anhydrate.

圖1是白克列的無水物的結晶變體II之IR光譜;以及圖2是白克列的無水物的結晶變體I之IR光譜。 Fig. 1 is the IR spectrum of the crystalline modification II of Becquel’s anhydrate; and Fig. 2 is the IR spectrum of the crystalline modification I of Becquel’s anhydrate.

因此,在第一方面,本發明提供製備白克列無水物的結晶變體II之方法,該方法包括提供在有機溶劑系統中的白克列溶液,將該溶液加熱到升高的溫度,並從該溶液中沈澱固體白克列,其中該升高的溫度足以優先形成白克列無水物的結晶變體II。 Therefore, in a first aspect, the present invention provides a method for preparing the crystalline modification II of Beklitz anhydride, the method comprising providing a Beklell solution in an organic solvent system, heating the solution to an elevated temperature, and From this solution, a solid beakley was precipitated, wherein the elevated temperature was sufficient to preferentially form crystalline modification II of the beakley anhydrous.

在本發明中,使用升高的溫度來形成白克列無水物之結晶變體II。如上所述,與較低的溫度相比,這種升高的溫度導致優先形成白克列無水物的結晶變體II。 In the present invention, the elevated temperature is used to form the crystalline modification II of Becquel anhydride. As mentioned above, this increased temperature results in the preferential formation of crystalline modification II of Becquel anhydride compared to lower temperatures.

本發明的方法採用白克列起始材料。該白克列起始材料是白克列在有機溶劑系統中的溶液。可以使用任何對於白克列合適的有機溶劑系統來形成本具體實施例所述的白克列起始材料。該溶劑系統可以是單一有機溶劑或兩種或更多種溶劑的混合物。合適的溶劑包括極性有機溶劑和芳香烴。較佳的極性有機溶劑是醇,包括多元醇,例如乙二醇,酮,醚,酯,醯胺及其混合物。 The method of the present invention uses Beckert starting material. The starting material of Beikelie is a solution of Beikelie in an organic solvent system. Any organic solvent system suitable for Beakley can be used to form the Beakley starting material described in this embodiment. The solvent system can be a single organic solvent or a mixture of two or more solvents. Suitable solvents include polar organic solvents and aromatic hydrocarbons. The preferred polar organic solvents are alcohols, including polyols, such as glycols, ketones, ethers, esters, amides and mixtures thereof.

合適的醇的實例是C1至C8醇,較佳的是C1至C5醇。該醇可以是直鏈或支鏈脂肪醇,更較佳的是乙醇、丙醇和丁醇。該醇可以是脂環族醇,例如環己醇。該溶劑可以包含多元醇,例如乙二醇。合適的乙二醇的實例是單乙二醇和聚乙二醇,較佳的是乙二醇和二甘醇。 Examples of suitable alcohols are C 1 to C 8 alcohols, preferably C 1 to C 5 alcohols. The alcohol may be a linear or branched fatty alcohol, more preferably ethanol, propanol and butanol. The alcohol may be an alicyclic alcohol, such as cyclohexanol. The solvent may contain polyols, such as ethylene glycol. Examples of suitable glycols are monoethylene glycol and polyethylene glycol, preferably ethylene glycol and diethylene glycol.

合適的酮的實例是C3至C8酮,較佳的是C3至C6酮,更較佳的是丙酮、丁酮、戊酮和己酮。該等酮可以是直鏈、支鏈或環狀的,例如烷基丙酮和環己酮。 Examples of suitable ketones are C 3 to C 8 ketones, preferably C 3 to C 6 ketones, more preferably acetone, methyl ethyl ketone, pentanone and hexanone. The ketones can be linear, branched or cyclic, such as alkylacetone and cyclohexanone.

合適的醚的實例是C3至C8醚,較佳的是C3至C6醚。該等醚可以是直鏈、支鏈或環狀的,例如二噁烷和四氫呋喃。 Examples of suitable ethers are C 3 to C 8 ethers, preferably C 3 to C 6 ethers. These ethers can be linear, branched or cyclic, such as dioxane and tetrahydrofuran.

合適的酯的實例是C3至C8酯,較佳的是C3至C6酯,更較佳的是乙酸乙酯和乙酸甲酯。 Examples of suitable esters are C 3 to C 8 esters, preferably C 3 to C 6 esters, more preferably ethyl acetate and methyl acetate.

合適的醯胺的實例是C3至C8醯胺,較佳的是C3至C6醯胺,更較佳的是二甲基甲醯胺。 Examples of suitable amides are C 3 to C 8 amides, preferably C 3 to C 6 amides, and more preferably dimethylformamide.

合適的芳香族溶劑是苯、甲苯和二甲苯。二甲苯是一種較佳的溶劑。 Suitable aromatic solvents are benzene, toluene and xylene. Xylene is a better solvent.

合適的溶劑是本領域已知的,並且是可商購的。 Suitable solvents are known in the art and are commercially available.

可以採用溶劑的混合物作為該溶劑系統。例如,該有機溶劑可以包括芳香族溶劑(如苯,二甲苯或甲苯)或環狀烷烴(如環己烯)與一種或多種脂肪族或脂環族醇(如環己醇)、一種或多種酮、一種或多種醚(例如環醚,如四氫呋喃)或一種或多種醯胺的組合。 A mixture of solvents can be used as the solvent system. For example, the organic solvent may include aromatic solvents (such as benzene, xylene or toluene) or cyclic alkanes (such as cyclohexene) and one or more aliphatic or alicyclic alcohols (such as cyclohexanol), one or more Combinations of ketones, one or more ethers (e.g. cyclic ethers such as tetrahydrofuran) or one or more amides.

本發明的方法中所採用的有機溶劑較佳的是基本上不含水,以確保白克列的無水物的最大生產率。該有機溶劑可以包含最高達按重量計0.4%的水,該水可以由大氣中的溶劑吸收。最佳的是,該有機溶劑也不含水。 The organic solvent used in the method of the present invention is preferably substantially free of water, so as to ensure the maximum productivity of the anhydrate of Becquel. The organic solvent may contain up to 0.4% by weight of water, which can be absorbed by the solvent in the atmosphere. Most preferably, the organic solvent does not contain water.

白克列溶液可以以任何合適的方式形成。例如,可以藉由將白克列的除固體結晶變體II之外的其它形式溶解在有機溶劑系統中來形成該溶液。或者,可在有機溶劑的存在下合成白克列。在有機溶劑中的溶液中合成白克列的合適方法是本領域已知的。US 7,087,239揭露用於製備白克列的合適的合成路徑。 The Beakley solution can be formed in any suitable way. For example, the solution can be formed by dissolving other forms of Becquerie other than solid crystal modification II in an organic solvent system. Alternatively, Becquel can be synthesized in the presence of an organic solvent. Suitable methods for synthesizing Beakley in solution in organic solvents are known in the art. US 7,087,239 discloses a suitable synthetic route for the preparation of Beakley.

本發明的方法包括從白克列在有機溶劑中的溶液中沈澱固體白克列。將該溶液加熱至升高的溫度。該升高的溫度高於環境溫度或室溫,並且是沈澱優先產生白克列無水物的結晶變體II的溫度。可以採用任何合適的升高的溫度。較佳的是,該升高的溫度低於白克列溶液的沸點。 The method of the present invention involves precipitating a solid bacillus from a solution of bacillus in an organic solvent. The solution is heated to an elevated temperature. This elevated temperature is higher than ambient temperature or room temperature, and is the temperature at which the precipitation preferentially produces crystalline modification II of bucklean anhydride. Any suitable elevated temperature can be used. Preferably, the elevated temperature is lower than the boiling point of the Becquerie solution.

合適的升高的溫度可以藉由分析沈澱的白克列材料來確定,特別是確定溫度是否足夠高,以使白克列無水物的變體II沈澱。 The appropriate elevated temperature can be determined by analyzing the precipitated Beakley material, in particular whether the temperature is high enough to allow the Beakley anhydrous variant II to precipitate.

該升高溫度較佳的是至少35℃,更佳的是至少40℃,進一步較佳的是至少45℃。在實驗中,已經發現,加熱至45℃的溫度後,從有機溶劑中的溶液中沈澱白克列產生包含按重量計30%的量的結晶變體II的固體白克列材料。 The elevated temperature is preferably at least 35°C, more preferably at least 40°C, and still more preferably at least 45°C. In experiments, it has been found that after heating to a temperature of 45° C., precipitation of white kraft from a solution in an organic solvent produces a solid white kraft material containing crystalline modification II in an amount of 30% by weight.

更佳的是,在加熱至至少50℃,還更佳的是至少55℃,更較佳的是仍然至少60℃的溫度之後,將白克列從溶液中沈澱出來。在實驗中,已經發現,加熱到65℃的溫度後,從有機溶劑中的溶液中沈澱固體白克列導致形成按重量計100%的白克列無水物的結晶變體II。 More preferably, after heating to a temperature of at least 50°C, still more preferably at least 55°C, and still more preferably still at least 60°C, the beakley is precipitated from the solution. In experiments, it has been found that after heating to a temperature of 65°C, precipitation of solid white crepe from a solution in an organic solvent leads to the formation of 100% by weight crystalline modification II of white crepe anhydride.

如上所述,該升高的溫度較佳的是低於有機溶劑和白克列起始材料的溶液之沸點。該升高的溫度也低於白克列無水物的結晶變體II的熔點。 As mentioned above, the elevated temperature is preferably lower than the boiling point of the solution of the organic solvent and Becquerie starting material. This elevated temperature is also lower than the melting point of crystalline modification II of Becquerie anhydride.

該升高的溫度的上限將取決於所採用的特定溶劑或溶劑系統。該升高的溫度較佳的是低於140℃,更佳的是低於130℃,還更佳的是 低於120℃,更較佳的是仍然低於110℃。在較佳的具體實施例中,將固體白克列起始材料加熱至低於100℃,更佳的是低於90℃,還更佳的是低於85℃,更較佳的是仍然低於80℃的升高溫度。 The upper limit of this elevated temperature will depend on the particular solvent or solvent system used. The elevated temperature is preferably lower than 140°C, more preferably lower than 130°C, still more preferably lower than 120°C, and still more preferably still lower than 110°C. In a preferred embodiment, the solid Becquel starting material is heated to less than 100°C, more preferably less than 90°C, still more preferably less than 85°C, more preferably still low At an elevated temperature of 80°C.

較佳的是使用從30℃至130℃範圍內的升高的溫度,更佳的是從35℃至120℃,進一步更佳的是從40℃至110℃,更較佳的是仍然為從45℃至100℃,其中較佳的溫度範圍為從50℃至90℃,更佳的是從55℃至85℃,進一步更佳的是從60℃至80℃。從60℃至70℃的溫度是特別較佳的,其中約65℃的溫度導致形成基本上按重量計100%的白克列無水物的變體II。 It is preferable to use an elevated temperature in the range from 30°C to 130°C, more preferably from 35°C to 120°C, still more preferably from 40°C to 110°C, and more preferably still from 45°C to 100°C, wherein the preferred temperature range is from 50°C to 90°C, more preferably from 55°C to 85°C, and still more preferably from 60°C to 80°C. Temperatures from 60°C to 70°C are particularly preferred, wherein a temperature of about 65°C results in the formation of substantially 100% by weight of Becquerel anhydride variant II.

可使用任何合適的技術來進行從有機溶劑中沈澱出白克列材料。從溶液中沈澱出白克列可以在升高的溫度下進行。例如,可以藉由例如藉由蒸發,例如在減壓下於升高的溫度下除去有機溶劑來進行沈澱。 Any suitable technique can be used to carry out the precipitation of the Becquerie material from the organic solvent. Precipitation of Beakley from solution can be carried out at elevated temperature. For example, the precipitation can be carried out by, for example, by evaporation, for example, by removing the organic solvent at an elevated temperature under reduced pressure.

或者,在將溶液加熱至升高的溫度之後,可在低於該升高的溫度之溫度下進行從溶液中沈澱出白克列。特別地,可以藉由將溶劑中的白克列飽和溶液從升高的溫度冷卻至發生固體白克列沈澱的較低溫度來實現從有機溶劑沈澱出白克列材料。 Alternatively, after the solution has been heated to an elevated temperature, the precipitation of beakley from the solution can be performed at a temperature lower than the elevated temperature. In particular, it is possible to realize the precipitation of the white kraft material from the organic solvent by cooling the saturated solution of white krafter in the solvent from an elevated temperature to a lower temperature at which solid white kraft precipitation occurs.

作為另外的替代方案,該方法可以採用上述技術的組合,即可以在升高的溫度下開始固體白克列材料的沈澱,並且然後冷卻溶液,例如使另外的固體沈澱。 As a further alternative, the method may use a combination of the above-mentioned techniques, that is, the precipitation of the solid beakley material may be started at an elevated temperature, and then the solution may be cooled, for example, to precipitate additional solids.

冷卻可以連續、逐步或以其組合的方式進行。 Cooling can be performed continuously, stepwise, or in a combination thereof.

白克列產物的沈澱可以在有機溶劑中在白克列的晶種的存在下進行,較佳的是白克列無水物的結晶變體II的晶種的存在下進行。 The precipitation of the Bekrief product can be carried out in an organic solvent in the presence of seed crystals of Bekrief, preferably in the presence of seed crystals of the crystal modification II of Bekrief anhydride.

本發明的方法可以分批進行或以連續方式進行。 The method of the present invention can be carried out batchwise or in a continuous manner.

可以使用任何合適的裝置來進行白克列結晶變體II的沈 澱。合適的裝置在本領域中是已知的,並且是可商購的。 Any suitable device can be used to carry out the precipitation of Beakley Crystal Modification II. Suitable devices are known in the art and are commercially available.

在另一方面,本發明提供包含藉由上述方法製備的白克列無水物的結晶變體II的殺真菌配製物。 In another aspect, the present invention provides a fungicidal formulation comprising the crystalline modification II of Becquel anhydride prepared by the method described above.

僅為了例示的目的藉由下列具體實例描述本發明的實施方式。 The embodiments of the present invention are described by the following specific examples for illustrative purposes only.

在以下實例中,除非另有說明,百分比是重量百分比。 In the following examples, unless otherwise stated, percentages are percentages by weight.

實例Instance

實例1Example 1

根據以下通用反應方案進行製備白克列:

Figure 106126004-A0202-12-0009-3
The Becquerie was prepared according to the following general reaction scheme:
Figure 106126004-A0202-12-0009-3

如下製備在二甲苯中的白克列溶液: The Becquerie solution in xylene was prepared as follows:

將311g的二甲苯中的396g(1.944mol)的2-胺基-4'-氯聯苯裝入到反應容器中,並攪拌該混合物直到得到均勻的溶液。將在233g的二甲苯中的349g(1.984mol)的2-氯-3-菸鹼基氯化物溶液添加到該反應容器中,並允許所得混合物加熱至30℃。 396 g (1.944 mol) of 2-amino-4'-chlorobiphenyl in 311 g of xylene was charged into the reaction vessel, and the mixture was stirred until a uniform solution was obtained. 349 g (1.984 mol) of 2-chloro-3-nicotinyl chloride solution in 233 g of xylene was added to the reaction vessel, and the resulting mixture was allowed to heat to 30°C.

將所得混合物在4至5小時的時間內加熱至95℃的升高的溫度。使用外部洗滌器並使用水和鹼溶液藉由噴霧塔進行吸收除去由反應產生的氯化氫(HCl)。將該反應混合物在相同的升高的溫度下伴隨攪拌進一步保持30分鐘,以除去所有HCL的所有痕跡。此後,將該反應混合物在5至7小時的時間內伴隨緩慢攪拌冷卻至30℃。 The resulting mixture is heated to an elevated temperature of 95°C over a period of 4 to 5 hours. Use an external scrubber and use water and alkali solution to absorb and remove the hydrogen chloride (HCl) generated by the reaction through a spray tower. The reaction mixture was kept at the same elevated temperature with stirring for a further 30 minutes to remove all traces of all HCL. Thereafter, the reaction mixture was cooled to 30°C with slow stirring over a period of 5 to 7 hours.

最後將該溶液冷卻至室溫,導致沈澱出固體白克列材料,藉由過濾除去溶液。藉由在烘箱中真空乾燥從該沈澱物中除去二甲苯痕跡。 Finally, the solution was cooled to room temperature, resulting in the precipitation of solid bacillus material, and the solution was removed by filtration. Traces of xylene were removed from the precipitate by vacuum drying in an oven.

使用布魯克公司(Bruker)型號Tensor 37光譜儀(記錄波長為550至4000cm-1,具有最高解析度為4cm-1的16次掃描),採用紅外(IR)光譜法分析回收的白克列材料。分析顯示該固體產物是白克列無水物的結晶變體II。 Using a Bruker model Tensor 37 spectrometer (recording wavelength of 550 to 4000 cm -1 , 16 scans with a maximum resolution of 4 cm -1 ), infrared (IR) spectroscopy was used to analyze the recovered Beikelie material. The analysis showed that the solid product was the crystalline modification II of Becquel anhydride.

實例2Example 2

將750g的甲苯在氮氣氣氛下裝入到反應容器中。在室溫下伴隨攪拌添加335g的2-氯菸鹼酸。向該混合物中添加35g的二甲基甲醯胺(DMF),並將所得反應混合物在攪拌下緩慢加熱至40℃。在1小時的時間內添加300g的亞硫醯氯。藉由洗滌除去反應釋放的氯化氫(HCl)和二氧化硫(SO2)。此後,將該反應物料保持在氮氣氛下,並在60℃下保持4至5小時,直至發生酸的完全反應(用HPLC進行監測)。之後,在60℃至75℃下在減壓下除去過量的亞硫醯氯。將所得混合物冷卻至室溫。 750 g of toluene was charged into the reaction vessel under a nitrogen atmosphere. 335 g of 2-chloronicotinic acid was added with stirring at room temperature. 35 g of dimethylformamide (DMF) was added to the mixture, and the resulting reaction mixture was slowly heated to 40°C under stirring. Add 300 g of sulfite chloride in a period of 1 hour. The hydrogen chloride (HCl) and sulfur dioxide (SO 2 ) released by the reaction are removed by washing. Thereafter, the reaction mass was kept under a nitrogen atmosphere and maintained at 60°C for 4 to 5 hours until complete acid reaction (monitored by HPLC) occurred. After that, excess thiol chloride was removed under reduced pressure at 60°C to 75°C. The resulting mixture was cooled to room temperature.

將冷卻的混合物在攪拌下用500g的甲苯和200g的三乙胺(TEA)稀釋。在45℃下,在30至45分鐘的時間內向此均勻混合物中添加400g的4'-氯聯苯-2-胺,並且再攪拌該混合物4至5小時使反應完成。藉由添加水並再攪拌2至3小時淬滅該混合物。 The cooled mixture was diluted with 500 g of toluene and 200 g of triethylamine (TEA) under stirring. At 45°C, 400 g of 4'-chlorobenzidine-2-amine is added to this homogeneous mixture within 30 to 45 minutes, and the mixture is stirred for another 4 to 5 hours to complete the reaction. The mixture was quenched by adding water and stirring for another 2 to 3 hours.

將有機層分離並保持在60℃之升高的溫度。過濾該混合物以除去不溶性雜質。在緩慢攪拌下將該混合物最終冷卻至10℃至15℃。藉由過濾並乾燥分離固體,得到450至480g的白克列。 The organic layer was separated and maintained at an elevated temperature of 60°C. The mixture is filtered to remove insoluble impurities. The mixture was finally cooled to 10°C to 15°C under slow stirring. The solid was separated by filtration and drying to obtain 450 to 480 g of Beak Lie.

如實例1中藉由IR光譜分析該固體,這顯示該固體產物是白克列無水物的結晶變體II。 The solid product was analyzed by IR spectroscopy as in Example 1, which showed that the solid product was the crystalline modification II of the anhydride of Becleter.

實例3Example 3

將於622g的二甲苯中的792g(3.888mol)的2-胺基-4'-氯聯苯裝入到反應容器中,並攪拌該混合物直到得到均勻的溶液。將在466g的二甲苯中的698g(3.968mol)的2-氯-3-菸鹼基氯化物溶液添加到該反應容器中,並允許所得混合物加熱至30℃的溫度。 792 g (3.888 mol) of 2-amino-4'-chlorobiphenyl in 622 g of xylene was charged into the reaction vessel, and the mixture was stirred until a uniform solution was obtained. A solution of 698 g (3.968 mol) of 2-chloro-3-nicotinyl chloride in 466 g of xylene was added to the reaction vessel, and the resulting mixture was allowed to heat to a temperature of 30°C.

將所得混合物在4至5小時的時間內加熱至95℃之升高的溫度。使用外部洗滌器並使用水和鹼溶液藉由噴霧塔進行吸收除去由反應產生的氯化氫(HCl)。將該反應混合物在相同的升高的溫度下伴隨攪拌進一步保持從2至3小時之時間,以除去所有HCl的所有痕跡。 The resulting mixture is heated to an elevated temperature of 95°C over a period of 4 to 5 hours. Use an external scrubber and use water and alkali solution to absorb and remove the hydrogen chloride (HCl) generated by the reaction through a spray tower. The reaction mixture was kept at the same elevated temperature with stirring for a further period of from 2 to 3 hours to remove all traces of HCl.

將所得混合物用白克列無水物的結晶變體II的晶種接種,導致固體材料的沈澱,藉由過濾收集該固體材料。藉由在烘箱中真空乾燥從該沈澱物中除去二甲苯痕跡。 The resulting mixture was inoculated with seed crystals of crystalline modification II of Bekley anhydride, which resulted in the precipitation of solid material, which was collected by filtration. Traces of xylene were removed from the precipitate by vacuum drying in an oven.

使用布魯克公司(Bruker)型號Tensor 37光譜儀(記錄波長為550至4000cm-1,具有最高解析度為4cm-1的16次掃描),採用紅外(IR)光譜法分析收集的固體材料。分析顯示該固體產物是白克列無水物的結晶變體II。 Using Bruker model Tensor 37 spectrometer (recording wavelength from 550 to 4000 cm -1 , 16 scans with a maximum resolution of 4 cm -1 ), infrared (IR) spectroscopy was used to analyze the collected solid materials. The analysis showed that the solid product was the crystalline modification II of Becquel anhydride.

實例4Example 4

按照實例2中描述的步驟製備375g的氯菸鹼酸的羰基中間體,並與400g的4'-氯聯苯-2-胺反應,得到粗製的白克列產物。將該產物用四氫呋喃(THF)反復洗滌,並用850g的異丙醇稀釋。將所得溶液加熱至60℃並在該溫度下保持2至3小時。 According to the procedure described in Example 2, 375 g of the carbonyl intermediate of chloronicotinic acid was prepared, and reacted with 400 g of 4'-chlorobenzidine-2-amine to obtain the crude Becquerie product. The product was washed repeatedly with tetrahydrofuran (THF) and diluted with 850 g of isopropanol. The resulting solution is heated to 60°C and maintained at this temperature for 2 to 3 hours.

冷卻所得混合物以獲得固體沈澱物。藉由過濾和乾燥分離該固體。 The resulting mixture was cooled to obtain a solid precipitate. The solid was separated by filtration and drying.

如實例1中藉由IR光譜分析該固體,其顯示該固體產物是白克列無水物的結晶變體II。 The solid product was analyzed by IR spectroscopy as in Example 1, which showed that the solid product was the crystalline modification II of Becquel anhydride.

為了研究溫度對該方法中得到的固體白克列材料的影響,重複實例1的步驟,其中在冷卻之前從保持在不同的升高的溫度範圍內的二甲苯溶液中沈澱出固體白克列。 In order to study the effect of temperature on the solid bacclair material obtained in the method, the procedure of Example 1 was repeated in which solid bacclair was precipitated from the xylene solution maintained in a different elevated temperature range before cooling.

結果總結在下表中。 The results are summarized in the table below.

從上表總結的結果可以看出,從有機溶劑中沈澱的白克列無水物的形式取決於從其中進行沈澱的白克列溶液的溫度。具體地,從加熱至65℃的溫度的二甲苯的沈澱產生了100%白克列無水物的結晶變體II。相比之下,從加熱到剛好30℃的二甲苯溶液的沈澱僅產生了10%至20%的白克列無水物的結晶變體II,在該溫度下主要形成了白克列無水物的結晶變體I。 From the results summarized in the above table, it can be seen that the form of the bacillus claret anhydride precipitated from the organic solvent depends on the temperature of the bacillus claret solution from which the precipitation is carried out. Specifically, the precipitation from xylene heated to a temperature of 65° C. produced 100% crystalline modification II of the white crepe anhydride. In contrast, from the precipitation of the xylene solution heated to just 30°C, only 10% to 20% of the crystalline modification II of the white creline anhydride was produced. Crystal Modification I.

Claims (23)

一種製備白克列無水物的結晶變體II之方法,該方法包括提供在有機溶劑系統中的白克列溶液,將該溶液加熱到升高的溫度,並從該溶液中沈澱固體白克列,該升高的溫度足以優先形成白克列無水物的結晶變體II,其中該升高溫度為至少35℃且低於140℃,並且其中固體白克列沈澱在該升高的溫度下發生。 A method for preparing the crystalline modification II of Beak Lite anhydride, the method comprising providing a Beak Lite solution in an organic solvent system, heating the solution to an elevated temperature, and precipitating a solid Beak Lite from the solution , The elevated temperature is sufficient to preferentially form crystalline modification II of the buckle anhydride, wherein the elevated temperature is at least 35°C and less than 140°C, and wherein the precipitation of solid buckleite occurs at the elevated temperature . 如申請專利範圍第1項所述之方法,其中該溶劑系統包含極性有機溶劑、芳香族烴或其混合物。 The method described in item 1 of the scope of the patent application, wherein the solvent system comprises a polar organic solvent, an aromatic hydrocarbon or a mixture thereof. 如申請專利範圍第2項所述之方法,其中該極性有機溶劑選自醇、酮、醚、酯、醯胺,及其混合物。 The method described in item 2 of the patent application, wherein the polar organic solvent is selected from alcohols, ketones, ethers, esters, amides, and mixtures thereof. 如申請專利範圍第3項所述之方法,其中該醇是直鏈或支鏈脂族醇或脂環族醇。 The method described in item 3 of the scope of the patent application, wherein the alcohol is a linear or branched aliphatic alcohol or a cycloaliphatic alcohol. 如申請專利範圍第4項所述之方法,其中該醇選自乙醇、丙醇、丁醇、環己醇、乙二醇和二甘醇。 The method described in item 4 of the scope of patent application, wherein the alcohol is selected from ethanol, propanol, butanol, cyclohexanol, ethylene glycol and diethylene glycol. 如申請專利範圍第3項所述之方法,其中該酮選自丙酮、丁酮、戊酮和己酮。 The method according to item 3 of the scope of patent application, wherein the ketone is selected from acetone, methyl ethyl ketone, pentanone and hexanone. 如申請專利範圍第3項所述之方法,其中該醚選自二噁烷和四氫呋喃。 The method described in item 3 of the scope of patent application, wherein the ether is selected from dioxane and tetrahydrofuran. 如申請專利範圍第3項所述之方法,其中該酯選自乙酸乙酯和乙酸甲酯。 The method described in item 3 of the scope of patent application, wherein the ester is selected from ethyl acetate and methyl acetate. 如申請專利範圍第3項所述之方法,其中該醯胺是二甲基甲醯胺。 The method described in item 3 of the scope of patent application, wherein the amide is dimethylformamide. 如申請專利範圍第2項所述之方法,其中該芳香族溶劑選自苯、甲苯和二甲苯。 The method described in item 2 of the scope of patent application, wherein the aromatic solvent is selected from benzene, toluene and xylene. 如申請專利範圍第1至10項中任一項所述之方法,其中該溶劑系統基本上不含水。 The method according to any one of items 1 to 10 in the scope of the patent application, wherein the solvent system is substantially free of water. 如申請專利範圍第1至10項中任一項所述之方法,其中可以藉由將白克 列的除固體結晶變體II之外的其他形式溶解在有機溶劑系統中來形成該溶液。 Such as the method described in any one of items 1 to 10 in the scope of the patent application, wherein the method can be The other forms listed in addition to the solid crystal modification II are dissolved in an organic solvent system to form the solution. 如申請專利範圍第1至10項中任一項所述之方法,其中藉由在有機溶劑系統的存在下合成白克列來形成該溶液。 The method according to any one of items 1 to 10 in the scope of the patent application, wherein the solution is formed by synthesizing Beakley in the presence of an organic solvent system. 如申請專利範圍第1至10項中任一項所述之方法,其中該升高的溫度低於該溶液之沸點。 The method according to any one of items 1 to 10 in the scope of the patent application, wherein the elevated temperature is lower than the boiling point of the solution. 如申請專利範圍第1至10項中任一項所述之方法,其中該升高的溫度為至少45℃。 The method according to any one of items 1 to 10 in the scope of the patent application, wherein the elevated temperature is at least 45°C. 如申請專利範圍第15項所述之方法,其中該升高的溫度為至少55℃。 The method described in item 15 of the scope of patent application, wherein the elevated temperature is at least 55°C. 如申請專利範圍第16項所述之方法,其中該升高的溫度為至少65℃。 The method described in item 16 of the scope of the patent application, wherein the elevated temperature is at least 65°C. 如申請專利範圍第1至10項中任一項所述之方法,其中該升高的溫度低於100℃。 The method according to any one of items 1 to 10 in the scope of the patent application, wherein the elevated temperature is lower than 100°C. 如申請專利範圍第18項所述之方法,其中該升高的溫度低於85℃。 The method described in item 18 of the scope of patent application, wherein the elevated temperature is less than 85°C. 如申請專利範圍第19項所述之方法,其中該升高的溫度為從55℃至85℃。 The method described in item 19 of the scope of the patent application, wherein the elevated temperature is from 55°C to 85°C. 如申請專利範圍第1至10項中任一項所述之方法,其中藉由向該溶液中添加晶種來幫助沈澱。 The method described in any one of items 1 to 10 in the scope of the patent application, wherein the precipitation is aided by adding seed crystals to the solution. 如申請專利範圍第21項所述之方法,其中該等晶種是白克列無水物的結晶變體II之晶體。 The method described in item 21 of the scope of patent application, wherein the seed crystals are the crystals of the crystal modification II of Bekley anhydride. 如申請專利範圍第1至10項中任一項所述之方法,其中該方法是分批進行或以連續方式進行。 The method according to any one of items 1 to 10 in the scope of the patent application, wherein the method is carried out in batches or in a continuous manner.
TW106126004A 2016-08-04 2017-08-02 Process for preparing boscalid TWI733869B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1613462.9A GB2552699B (en) 2016-08-04 2016-08-04 Process for preparing boscalid
GB1613462.9 2016-08-04
??1613462.9 2016-08-04

Publications (2)

Publication Number Publication Date
TW201808904A TW201808904A (en) 2018-03-16
TWI733869B true TWI733869B (en) 2021-07-21

Family

ID=60940414

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106126004A TWI733869B (en) 2016-08-04 2017-08-02 Process for preparing boscalid

Country Status (4)

Country Link
CN (1) CN109476603A (en)
GB (1) GB2552699B (en)
TW (1) TWI733869B (en)
WO (1) WO2018024145A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023062649A1 (en) * 2021-10-14 2023-04-20 Natco Pharma Limited An improved process for the preparation of anhydrous crystalline form-i of boscalid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1575281A (en) * 2001-11-02 2005-02-02 巴斯福股份公司 Method for producing 2-halogen-pyridine-carboxylic acid amides
US7501384B2 (en) * 2003-02-14 2009-03-10 Basf Aktiengesellschaft Crystalline modification of the anhydrate of boscalid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA007780B1 (en) * 2001-09-25 2007-02-27 Басф Акциенгезельшафт Crystalline hydrates of nicotinic acid anilide derivatives
CN103073489A (en) * 2013-02-06 2013-05-01 利民化工股份有限公司 Preparation method of Boscalid
CN103980192B (en) * 2014-01-20 2016-02-17 泰州百力化学股份有限公司 A kind of method of selectivity synthesis different crystal forms boscalid amine
CN105541709A (en) * 2016-02-25 2016-05-04 尚振华 Method for preparing boscalid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1575281A (en) * 2001-11-02 2005-02-02 巴斯福股份公司 Method for producing 2-halogen-pyridine-carboxylic acid amides
US7501384B2 (en) * 2003-02-14 2009-03-10 Basf Aktiengesellschaft Crystalline modification of the anhydrate of boscalid

Also Published As

Publication number Publication date
GB2552699A (en) 2018-02-07
WO2018024145A1 (en) 2018-02-08
GB2552699B (en) 2021-03-10
CN109476603A (en) 2019-03-15
TW201808904A (en) 2018-03-16

Similar Documents

Publication Publication Date Title
JP5305248B2 (en) New nateglinide crystals
US10364225B2 (en) Process for preparing boscalid
HUE029401T2 (en) Process for preparing tiotropium bromide
TWI733869B (en) Process for preparing boscalid
TWI756173B (en) Process for preparing boscalid
TWI750119B (en) Process for drying polymorph i of anhydrate of boscalid
KR20100045985A (en) Process for producing toluidine compound
US9233984B2 (en) Compound, method for producing compound, and method for purifying compound
TWI777967B (en) Process for preparing boscalid
TWI364282B (en) Cefcapene pivoxil methanesulfonic acid salt
AU2013368947A1 (en) Process for preparing amorphous Cabazitaxel
WO2018024146A1 (en) Process for preparation of boscalid
WO2015008973A1 (en) Method for preparing sarpogrelate hydrochloride crystal form ii
TW202237594A (en) Process for the production of 5-(4-((2s,5s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1h-1,2,4-triazol-3-amine
US9328115B2 (en) Process for preparing meropenem trihydrate
CN115703745A (en) Preparation method of enzalutamide
TWI261054B (en) Process for the preparation of 1,3-disubstituted 2-nitroguanidines
JPH09255644A (en) Production of adipic acid dihydrazide
WO1997001563A1 (en) Stable bicozamycin benzoate crystals
KR20120074856A (en) Novel crystalline form of linezolid acid additional salts and linezolid co-crystals

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees